These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 279321)

  • 21. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
    Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
    Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The borderline pituitary fossa in patients with amenorrhoea and/or galactorrhoea.
    Banna M; Nicholas W; McLachlan M
    Neuroradiology; 1978; 16():440-2. PubMed ID: 570652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG
    South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pregnancy and lactation on pituitary prolactin-secreting tumours.
    Zárate A; Canales ES; Alger M; Forsbach G
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):407-12. PubMed ID: 517046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
    Barreca P; Giannola C; Palisi F
    Acta Eur Fertil; 1978 Mar; 9(1):21-9. PubMed ID: 567920
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 31. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term treatment of galactorrhoea and hypogonadism with bromocriptine.
    Thorner MO; McNeilly AS; Hagan C; Besser GM
    Br Med J; 1974 May; 2(5916):419-22. PubMed ID: 4600593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia.
    Cuellar FG
    Obstet Gynecol; 1980 Mar; 55(3):278-84. PubMed ID: 6987580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hyperprolactinaemia and galactorrhoea in secondary amenorrhoea.
    Giwa-Osagie OF; Akinla OA; Coker OO; Sanyaolu AO
    Trop Geogr Med; 1983 Jun; 35(2):163-5. PubMed ID: 6684337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of new diagnostic methods on the differential diagnosis and treatment of secondary amenorrhoea.
    Shearman RP; Fraser IS
    Lancet; 1977 Jun; 1(8023):1195-7. PubMed ID: 68286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of CV205-502 in patients with hyperprolactinaemia intolerant and/or resistant to bromocriptine.
    Razzaq R; O'Halloran DJ; Beardwell CG; Shalet SM
    Horm Res; 1993; 39(5-6):218-22. PubMed ID: 7906243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.